Q3/2024 9/30/2024 EPS -0.420 ZacksConsensus -0.440 ActVsEst 0.020 - Beat
Aura Biosciences, Inc. (AURA)
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
AURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AURA alerts
High impacting Aura Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
AURA
News
- Aura Biosciences, Inc. (NASDAQ: AURA) was given a new $25.00 price target on by analysts at HC Wainwright.MarketBeat
- Aura Biosciences, Inc. (NASDAQ: AURA) was given a new $19.00 price target on by analysts at JMP Securities.MarketBeat
- Aura Biosciences, Inc. (NASDAQ: AURA) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..MarketBeat
- Aura Biosciences Announces Appointment of Teresa Bitetti to Board of DirectorsGlobeNewswire
- Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business HighlightsGlobeNewswire
AURA
Earnings
- 5/9/24 - Beat
AURA
Sec Filings
- 4/11/25 - Form SCHEDULE
- 4/2/25 - Form 4
- 4/2/25 - Form 3
- AURA's page on the SEC website